|
ATP6V1C1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.214200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.893700E-02 |
| Normal-vs-Stage2 |
9.730400E-01 |
| Normal-vs-Stage3 |
1.922790E-01 |
| Normal-vs-Stage4 |
6.673400E-01 |
| Stage1-vs-Stage2 |
3.016800E-01 |
| Stage1-vs-Stage3 |
4.536500E-02 |
| Stage1-vs-Stage4 |
2.327800E-01 |
| Stage2-vs-Stage3 |
2.287000E-01 |
| Stage2-vs-Stage4 |
6.661400E-01 |
| Stage3-vs-Stage4 |
5.830800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.449000E-01 |
| Normal-vs-AfricanAmerican |
4.759000E-01 |
| Normal-vs-Asian |
3.928000E-01 |
| Caucasian-vs-AfricanAmerican |
9.814000E-01 |
| Caucasian-vs-Asian |
3.419000E-01 |
| AfricanAmerican-vs-Asian |
3.441600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.315600E-02 |
| Normal-vs-Female |
3.595400E-01 |
| Male-vs-Female |
2.423800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.498800E-01 |
| Normal-vs-Extreme_Weight |
9.342700E-03 |
| Normal-vs-Obese |
9.367600E-01 |
| Normal-vs-Extreme_Obese |
5.785400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.769010E-01 |
| Normal_Weight-vs-Obese |
8.200400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.267000E-01 |
| Extreme_Weight-vs-Obese |
3.494100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.069200E-01 |
| Obese-vs-Extreme_Obese |
7.419400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.256200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.966200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.104500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.231800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.080400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.804380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.008250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.602200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.640800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.003800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.383340E-04 |
| Normal-VS-Type2 PRCC |
1.693910E-02 |
| Normal-VS-KIRP CIMP |
3.739000E-01 |
| Normal-VS-Unclassified PRCC |
7.551600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.74514999999875E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.335100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.717800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.416600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.688430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.767000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.112400E-01 |
| Normal-vs-N1 |
1.054220E-01 |
| Normal-vs-N2 |
5.224200E-01 |
| N0-vs-N1 |
3.728200E-01 |
| N0-vs-N2 |
6.410000E-01 |
| N1-vs-N2 |
9.538400E-01 |
|
|
